Literature DB >> 8392139

Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations.

Y Zhang1, T Garbe, D Young.   

Abstract

Isoniazid-resistant isolates of Mycobacterium tuberculosis were transformed with a plasmid vector carrying the functional catalase-peroxidase (katG) gene. Expression of katG restored full drug susceptibility in isolates initially resistant to concentrations ranging from 3.2 to > 50 micrograms ml-1. Transformation with the corresponding katG gene from Escherichia coli resulted in low-level expression of catalase and peroxidase activities and conferred partial isoniazid sensitivity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392139     DOI: 10.1111/j.1365-2958.1993.tb01596.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  49 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Nucleotide sequence of the Mycobacterium leprae katG region.

Authors:  N Nakata; M Matsuoka; Y Kashiwabara; N Okada; C Sasakawa
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Authors:  Rosilene Fressatti Cardoso; Robert C Cooksey; Glenn P Morlock; Patricia Barco; Leticia Cecon; Francisco Forestiero; Clarice Q F Leite; Daisy N Sato; Maria de Lourdes Shikama; Elsa M Mamizuka; Rosario D C Hirata; Mario H Hirata
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.

Authors:  B Saint-Joanis; H Souchon; M Wilming; K Johnsson; P M Alzari; S T Cole
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

5.  Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.

Authors:  Tali H Reingewertz; Tom Meyer; Fiona McIntosh; Jaryd Sullivan; Michal Meir; Yung-Fu Chang; Marcel A Behr; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 6.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

7.  Presence of katG gene in resistant Mycobacterium tuberculosis.

Authors:  M Jaber; A Rattan; R Kumar
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

Review 8.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

9.  Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA.

Authors:  R Frothingham; W A Meeker-O'Connell; E A Talbot; J W George; K N Kreuzer
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

10.  Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.

Authors:  B Heym; Y Zhang; S Poulet; D Young; S T Cole
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.